Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 7 | 2024 | 392 | 1.560 |
Why?
|
| Angiotensinogen | 3 | 2013 | 12 | 1.230 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2018 | 15 | 1.120 |
Why?
|
| Nephritis, Hereditary | 2 | 2024 | 6 | 1.000 |
Why?
|
| Hematuria | 1 | 2022 | 26 | 0.770 |
Why?
|
| Kidney | 3 | 2022 | 723 | 0.620 |
Why?
|
| Denys-Drash Syndrome | 1 | 2017 | 2 | 0.560 |
Why?
|
| WT1 Proteins | 1 | 2017 | 4 | 0.560 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2024 | 328 | 0.490 |
Why?
|
| Mutation | 2 | 2022 | 1344 | 0.490 |
Why?
|
| Pediatrics | 1 | 2018 | 295 | 0.460 |
Why?
|
| Collagen Type IV | 3 | 2024 | 12 | 0.460 |
Why?
|
| Renin | 1 | 2013 | 18 | 0.420 |
Why?
|
| Renin-Angiotensin System | 1 | 2013 | 58 | 0.410 |
Why?
|
| Intensive Care Units | 1 | 2013 | 236 | 0.360 |
Why?
|
| Predictive Value of Tests | 5 | 2014 | 952 | 0.300 |
Why?
|
| Prognosis | 6 | 2024 | 2118 | 0.290 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2024 | 8 | 0.230 |
Why?
|
| Complement C3 | 1 | 2024 | 20 | 0.230 |
Why?
|
| Podocytes | 1 | 2024 | 18 | 0.220 |
Why?
|
| Zebrafish | 1 | 2023 | 60 | 0.200 |
Why?
|
| Humans | 13 | 2025 | 52593 | 0.190 |
Why?
|
| Diabetic Nephropathies | 2 | 2013 | 61 | 0.190 |
Why?
|
| Pedigree | 1 | 2022 | 126 | 0.190 |
Why?
|
| Autoantigens | 1 | 2022 | 52 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 203 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 1037 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1081 | 0.160 |
Why?
|
| Aged | 5 | 2024 | 10191 | 0.150 |
Why?
|
| Female | 8 | 2025 | 28262 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2018 | 96 | 0.140 |
Why?
|
| Middle Aged | 6 | 2024 | 13096 | 0.140 |
Why?
|
| Brain | 1 | 2025 | 1325 | 0.130 |
Why?
|
| Area Under Curve | 2 | 2013 | 183 | 0.130 |
Why?
|
| Creatinine | 2 | 2013 | 159 | 0.130 |
Why?
|
| Disease Progression | 3 | 2013 | 873 | 0.130 |
Why?
|
| ROC Curve | 2 | 2013 | 254 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 295 | 0.120 |
Why?
|
| Child | 3 | 2025 | 7229 | 0.120 |
Why?
|
| Male | 8 | 2025 | 26863 | 0.120 |
Why?
|
| Logistic Models | 2 | 2013 | 934 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1048 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Haptoglobins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Animals | 5 | 2024 | 13507 | 0.100 |
Why?
|
| Infant | 2 | 2022 | 3720 | 0.100 |
Why?
|
| Suramin | 1 | 2012 | 10 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 242 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 602 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 313 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 137 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2013 | 459 | 0.090 |
Why?
|
| Risk Factors | 3 | 2013 | 3952 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 2 | 2025 | 130 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 3420 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 567 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2022 | 6671 | 0.060 |
Why?
|
| United States | 2 | 2013 | 5227 | 0.060 |
Why?
|
| Glomerular Basement Membrane | 1 | 2024 | 10 | 0.060 |
Why?
|
| Mice | 2 | 2024 | 5958 | 0.050 |
Why?
|
| Rats | 2 | 2024 | 3203 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2023 | 18 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2024 | 250 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2023 | 79 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 183 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1202 | 0.050 |
Why?
|
| Age Factors | 1 | 2025 | 1132 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2023 | 283 | 0.040 |
Why?
|
| Adult | 2 | 2013 | 14170 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 1545 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 3000 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4337 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2013 | 26 | 0.030 |
Why?
|
| Urinalysis | 1 | 2013 | 33 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6737 | 0.030 |
Why?
|
| Albuminuria | 1 | 2013 | 49 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 59 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 62 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 240 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 293 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 287 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 568 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 329 | 0.020 |
Why?
|
| Proteomics | 1 | 2013 | 327 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 216 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 1350 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1554 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5486 | 0.010 |
Why?
|